Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Beer

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Drugs in Dermatology : JDD|January 4, 2014
Aesthetic treatment considerations for the eyebrows and periorbital complexKenneth R Beer, Stephanie Bayers, Jacob Beer
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 27, 2013
Treatment of eyebrow hypotrichosis using bimatoprost: a randomized, double-blind, vehicle-controlled pilot studyKenneth R Beer, Hillary Julius, Monica Dunn, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|December 15, 2010
An open-label trial examining the efficacy and safety of a pre- and postprocedure topical five-product system (Clinique Medical Optimizing Regimen) specifically formulated to complement laser/light-based facial cosmetic proceduresVic A Narurkar, Kenneth R Beer, Joel L Cohen
Journal of Cosmetic Dermatology|June 10, 2014
Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxinKenneth R Beer, Hillary Julius, Monica Dunn, et al.
Journal of Drugs in Dermatology : JDD|October 3, 2013
Treatment of margin positive basal cell carcinoma with vismodegib: case report and consideration of treatment options and their implicationsStephanie Bayers, Daniel L Kapp, Kenneth R Beer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 6, 2015
Identification and management of mental health issues by dermatologic surgeons: a survey of American Society for Dermatologic Surgery membersDavid B Sarwer, Jacqueline C Spitzer, Joseph F Sobanko, et al.
Journal of the American Academy of Dermatology|February 6, 2010
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cyclesC William Hanke, Kenneth R Beer, Eggert Stockfleth, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 21, 2019
Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III StudiesKenneth R Beer, Ava Theresa Shamban, Rui L Avelar, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 15, 2021
Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA ProgramJoel L Cohen, Lawrence J Green, Kenneth R Beer, et al.
Journal of Drugs in Dermatology : JDD|January 4, 2011
Rapid onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar linesKenneth R Beer, Charles Boyd, Rina K Patel, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Drugs in Dermatology : JDD|January 4, 2014
Aesthetic treatment considerations for the eyebrows and periorbital complexKenneth R Beer, Stephanie Bayers, Jacob Beer
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 27, 2013
Treatment of eyebrow hypotrichosis using bimatoprost: a randomized, double-blind, vehicle-controlled pilot studyKenneth R Beer, Hillary Julius, Monica Dunn, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|December 15, 2010
An open-label trial examining the efficacy and safety of a pre- and postprocedure topical five-product system (Clinique Medical Optimizing Regimen) specifically formulated to complement laser/light-based facial cosmetic proceduresVic A Narurkar, Kenneth R Beer, Joel L Cohen
Journal of Cosmetic Dermatology|June 10, 2014
Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxinKenneth R Beer, Hillary Julius, Monica Dunn, et al.
Journal of Drugs in Dermatology : JDD|October 3, 2013
Treatment of margin positive basal cell carcinoma with vismodegib: case report and consideration of treatment options and their implicationsStephanie Bayers, Daniel L Kapp, Kenneth R Beer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 6, 2015
Identification and management of mental health issues by dermatologic surgeons: a survey of American Society for Dermatologic Surgery membersDavid B Sarwer, Jacqueline C Spitzer, Joseph F Sobanko, et al.
Journal of the American Academy of Dermatology|February 6, 2010
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cyclesC William Hanke, Kenneth R Beer, Eggert Stockfleth, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 21, 2019
Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III StudiesKenneth R Beer, Ava Theresa Shamban, Rui L Avelar, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 15, 2021
Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA ProgramJoel L Cohen, Lawrence J Green, Kenneth R Beer, et al.
Journal of Drugs in Dermatology : JDD|January 4, 2011
Rapid onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar linesKenneth R Beer, Charles Boyd, Rina K Patel, et al.
Pageof 3